A prospective analysis of vascular access device-related infections in children
To identify significant predictors of device-related infections, we performed a prospective, nonrandomized analysis of our experience with vascular access devices over a 2-year period in a pediatric oncology population. Variables analyzed included: (1) age at placement, (2) sex, (3) underlying disea...
Gespeichert in:
Veröffentlicht in: | Journal of pediatric surgery 1992-07, Vol.27 (7), p.840-842 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | To identify significant predictors of device-related infections, we performed a prospective, nonrandomized analysis of our experience with vascular access devices over a 2-year period in a pediatric oncology population. Variables analyzed included: (1) age at placement, (2) sex, (3) underlying disease, (4) type of device used (catheter
v port), and (5) total white blood cell count at placement. Quantitative microbiologic criteria were used for diagnosis of bacteremia while clinical and microbiologic criteria were used in diagnosis of tunnel/port/site infections. During the study period a total of 351 devices, comprising 78, 159 days in situ, were placed and data for univariate and multivariate analysis were available on 271 (77%). The mean age at placement was 7.2 ± 4.7 years for catheters and 9.5 ± 4.8 years for implantable devices (
P ≤ .01). Significant predictors of device-related infections in univariate analysis were type of device (
P ≤ .0001) and age (
P ≤ .002). External catheters and age ≤ 7 years were associated with increased risk of infection. Underlying disease had a marginal effect on the infection rate (
P = .08). In multivariate analysis, device type (
P ≤ .0001) and age (
P ≤ .002) continued to affect infections, whereas underlying disease demonstrated only a borderline effect (
P = .14). We conclude that device type and age significantly affect the rate of device-related infections. These data support increased use of implantable devices in pediatric oncology patients. |
---|---|
ISSN: | 0022-3468 1531-5037 |
DOI: | 10.1016/0022-3468(92)90379-L |